Navigation Links
China Biologic Products Announces First Quarter 2010 Results
Date:5/17/2010

ncontrolling interest shareholders (4,780,790) -- Net cash (used in) provided by financing activities (1,177,882) 7,647,822 EFFECTS OF EXCHANGE RATE CHANGE IN CASH (54,890) 72,655 (DECREASE) INCREASE IN CASH (2,653,526) 25,191,332 CASH and CASH EQUIVALENTS, beginning of year 53,843,951 8,814,616 CASH and CASH EQUIVALENTS, end of year $51,190,425 $34,005,948 SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Income taxes paid $3,806,691 $1,783,619 Interest paid (net of capitalized interest) $62,286 $236,649 Non-cash investing and financing activities: Reclassification of derivative liability to equity related to conversion of convertible notes $1,809,771 $-- Reclassification of derivative liability to equity related to exercise of warrants $2,436,907 $-- Distribution paid by offsetting accounts receivable - related party $-- $3,735,243 Net assets acquired with prepayments made in prior periods $-- $14,240,772 Net assets addition with unpaid commitment $395,540 $14,240,772 Plant and equipment acquired with prepayments made in prior periods $424,858 $87,305 For more information, please contact: Company Contact: Mr. Y. Tristan Kuo Chief Financial Officer China Biologic Products, Inc. Phone: +86-538-6202206 Email: '/>"/>
SOURCE China Biologic Products, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. China Sky One Medicals CEO Receives Award For "Leadership Excellence In Innovation"
2. China Sky One Medical to Attend Investment Conferences in May
3. China Biologic Products to Build Two New Plasma Stations in Shandong Province
4. China Nepstar Chain Drugstore Reschedules First Quarter 2010 Results to May 18
5. China Yongxin Pharmaceuticals is Selected as one of the Qualified Pharmaceutical Distributors for Jilin Province
6. China Pharma Holdings, Inc. Announces May Investor Conference Participation
7. China Nepstar Chain Drugstore Reports First Quarter 2010 Results on May 19
8. China Medical Technologies to Announce Results for the Fourth Fiscal Quarter and the Fiscal Year Ended March 31, 2010 on June 4, 2010
9. China Pharma Holdings, Inc. Retains CCG Investor Relations
10. China Medical Technologies to Participate in Investor Conferences in May and June 2010
11. Winner Medical Participates in CMEF 2010, China International Medical Equipment Fair, in Shenzhen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 EarlySense, the market ... the prize for ,Best Novel Idea, at the 8 ... Teams International Conference, hosted this year in the UK ... a clinical research team studying the impact of the ... Los Angeles . The prize was ...
(Date:5/23/2013)...  MedVantx, Inc., the company that has pioneered a ... the Company has completed a major expansion of its ... and the upgrade of its systems to offer a ... specialty home delivery pharmacy in Sioux Falls, ... physicians, health systems and payors novel distribution services, as ...
(Date:5/23/2013)... NEW YORK , May 23, 2013  Echo ... has committed to waive down the Acceptance Threshold from ... Affected plus one Elan Share in accordance with the ... to the conditions summarized below. Under the ... to acquire Elan (NYSE: ELN ) for ...
Breaking Medicine Technology:Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 2Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 3Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 4MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10
... , NEW YORK, ... research report is available in its catalogue: , ... 2009 (15 Countries) , http://www.reportlinker.com/p0166835/European-Markets-for-Drug-Eluting-and-Bare-Metal-Stents-2009-15-Countries.html ... encompasses Germany, France, the United Kingdom (U.K.), Italy, Spain, ...
... , NEW YORK, Dec. ... report is available in its catalogue: , Radiopharmaceuticals ... http://www.reportlinker.com/p0164273/Radiopharmaceuticals---A-US-and-European-Market-Analysis.html , The market for radiopharmaceuticals continues ... acceptance and utilization of nuclear medicine equipment, as well ...
Cached Medicine Technology:Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 2Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 3Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 4Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 5Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 6Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 7Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 2Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 3Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 4Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 5Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 6Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 7Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 8Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 9Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 10
(Date:5/23/2013)... May 24, 2013 On March 14, 2012, ... women will hear in her lifetime: she had breast cancer. ... Journey After a Breast Cancer Diagnosis ” (published by AuthorHouse), ... , Rideout drew from her daily journals to give readers ... surgery, chemotherapy and radiation treatments to deal with stage two ...
(Date:5/23/2013)... If you are one of the estimated ... the food spread this Memorial Day weekend could put ... dogs and ice cream have become cornerstones of the ... sufferers often feel the painful effects of consuming these ... Lourdes Medical Associates. , IBS occurs when the large ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Amirsys, ... comprehensive radiology learning environment for all resident levels ... and assessments, transforms the learning experience from case-based ... , “Until RADPrimer 3.0, RADPrimer heavily ... none,” comments Dr. B.J. Manaster, Professor of Radiology ...
(Date:5/23/2013)... 2013)Don,t doubt it when a woman harried by hot ... A new study published online in Menopause , ... helps confirm with objective tests that what these women ... past, some studies showed that hot flashes were related ... that, even though there was a relationship between hot ...
(Date:5/23/2013)... being dragged to its destruction inside a cell, ... signals that thwart the development of tumor-suppressing microRNAs ... early online publication at Nature . , ... tumors, the epidermal growth factor receptor (EGFR) gums ... led by scientists at The University of Texas ...
Breaking Medicine News(10 mins):Health News:Kimberley Rideout Shares Her Triumphant Cancer Survival Story 2Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 2Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 3Health News:RADPrimer 3.0 Introduces Comprehensive Radiology Training Curriculum 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 3
... WASHINGTON, Dec. 18 - In response to the,press ... E. Schumer (D-NY) of a bill -- S ... (DARA 2007)," -- which proposes to amend,the Controlled ... to minors and,create penalties to those who would ...
... America, the,fastest-growing Hispanic television network in the United States, ... this week,s broadcast of "Issues:,Caras y Voces" (Issues: Faces ... Dr. Huerta is the first Latino to assume the ... studied medicine at the University of San,Marcos and Johns ...
... Dec. 18 /PRNewswire-FirstCall/ - Aspreva Pharmaceuticals,Corporation (NASDAQ: ... British,Columbia Supreme Court has issued a final order ... (SWX: GALN), through a wholly-owned,Canadian subsidiary, will acquire ... US$26.00 per share in cash., The transaction, ...
... 18 Alsius Corporation,(Nasdaq: ALUS ), which ... announced today that the company has,launched offers to ... opportunity, for a limited time, to exercise the ... terms of the warrants to allow holders to,receive ...
... Royalty Pharma and Northwestern,University announced today that Northwestern ... in Lyrica(R) to Royalty Pharma for $700 million,in ... A portion of the payment to Northwestern will ... chemical compound that serves as the basis for,Lyrica(R)., ...
... SAN DIEGO, Dec. 18 Pacira Pharmaceuticals, ... today announced that,David M. Stack has been ... of the Board of Directors., (Logo: ... currently the CEO and founding partner of ...
Cached Medicine News:Health News:Council for Responsible Nutrition Calls Proposed DHEA Legislation 'A Solution in Search of a Problem' 2Health News:American Cancer Society President Elmer Huerta Shares Inspirational Message on Azteca America's 'Issues: Caras Y Voces' 2Health News:Aspreva receives final court approval for acquisition by Galenica 2Health News:Aspreva receives final court approval for acquisition by Galenica 3Health News:Aspreva receives final court approval for acquisition by Galenica 4Health News:Alsius Corporation Announces Program for Early Exercise of Warrants 2Health News:Alsius Corporation Announces Program for Early Exercise of Warrants 3Health News:Alsius Corporation Announces Program for Early Exercise of Warrants 4Health News:Royalty Pharma Acquires a Portion of Northwestern University's Royalty Interest in Lyrica(R) for $700 Million 2Health News:Royalty Pharma Acquires a Portion of Northwestern University's Royalty Interest in Lyrica(R) for $700 Million 3Health News:Pacira Pharmaceuticals Names David M. Stack CEO and President 2Health News:Pacira Pharmaceuticals Names David M. Stack CEO and President 3
... pipette management software enables you to ... assurance program. Use Pipette Tracker to ... automatically log data from PCS, set ... and create custom management and compliance ...
... the Jarvik 2000 pump is about the size ... shell sits a direct-current motor, a rotor supported ... part: a small, spinning titanium impeller that pumps ... liters per minute. Rather than take over for ...
... The InVance Male Sling System is ... for mild to moderate stress urinary incontinence ... a solution for men who are not ... to limited manual dexterity, limited mental capacity ...
... third generation cardiac assist system primarily designed as ... suffering heart failure., ,It is a blood pump ... diseased heart to help the ailing hearts pumping ... of life. , ,It can also be used ...
Medicine Products: